First report and detailed characterization of B. pertussis isolates not expressing pertussis toxin or pertactin
- 1 October 2009
- Vol. 27 (43) , 6034-6041
- https://doi.org/10.1016/j.vaccine.2009.07.074
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Genomic Content of Bordetella pertussis Clinical Isolates Circulating in Areas of Intensive Children VaccinationPLOS ONE, 2008
- Is the Sequenced Bordetella pertussis Strain Tohama I Representative of the Species?Journal of Clinical Microbiology, 2008
- Extensive Proliferation of Transposable Elements in Heritable Bacterial SymbiontsJournal of Bacteriology, 2008
- Comparative genomic profiling of Dutch clinical Bordetella pertussis isolates using DNA microarrays: Identification of genes absent from epidemic strainsBMC Genomics, 2008
- Comparative Genomics of Bordetella pertussis Reveals Progressive Gene Loss in Finnish StrainsPLOS ONE, 2007
- Transmission of Bordetella pertussis to Young InfantsThe Pediatric Infectious Disease Journal, 2007
- Significant Gene Order and Expression Differences inBordetella pertussisDespite Limited Gene Content VariationJournal of Bacteriology, 2006
- Polymorphism of Repeated Regions of Pertactin in Bordetella pertussis , Bordetella parapertussis , and Bordetella bronchisepticaInfection and Immunity, 2000
- Intranasal murine model of Bordetella pertussis infection: II. Sequence variation and protection induced by a tricomponent acellular vaccine1Financial support for the present study was provided by the Institut Pasteur Fondation and SmithKline Beecham Biologicals. All animal studies were conducted in accordance with the French and Belgian national legislative guidelines for animal experimentation.1Vaccine, 1999
- Intranasal murine model of Bordetella pertussis infection. I. Prediction of protection in human infants by acellular vaccinesVaccine, 1999